Veradigm Valuation
| MDRX Stock | USD 4.55 0.25 5.21% |
At this time, the company appears to be undervalued. Veradigm has a current Real Value of $4.87 per share. The regular price of the company is $4.55. Our model measures the value of Veradigm from inspecting the company fundamentals such as Operating Margin of 0.17 %, shares outstanding of 108.9 M, and Return On Equity of -0.0169 as well as reviewing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Veradigm's price fluctuation is slightly risky at this time. Calculation of the real value of Veradigm is based on 3 months time horizon. Increasing Veradigm's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Veradigm is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Veradigm Stock. However, Veradigm's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.55 | Real 4.87 | Hype 4.56 | Naive 4.49 |
The intrinsic value of Veradigm's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Veradigm's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Veradigm helps investors to forecast how Veradigm stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Veradigm more accurately as focusing exclusively on Veradigm's fundamentals will not take into account other important factors: Veradigm Total Value Analysis
Veradigm is now projected to have valuation of 268.35 M with market capitalization of 535.79 M, debt of 219.44 M, and cash on hands of 500.16 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Veradigm fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
268.35 M | 535.79 M | 219.44 M | 500.16 M |
Veradigm Investor Information
About 41.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.49. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Veradigm has Price/Earnings To Growth (PEG) ratio of 2.42. The entity recorded a loss per share of 0.18. The firm last dividend was issued on the 7th of October 2008. Veradigm is not in a good financial situation at this time. It has a very high odds of going through financial crisis in February.Veradigm Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Veradigm suggests not a very effective usage of assets in January.Veradigm Ownership Allocation
Veradigm shows a total of 108.9 Million outstanding shares. 30% of Veradigm outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. On November 14, 2019, Representative Peter Welch of US Congress acquired under $15k worth of Veradigm's common stock.Veradigm Profitability Analysis
The company reported the previous year's revenue of 588.02 M. Net Income was 134.44 M with profit before overhead, payroll, taxes, and interest of 308.42 M.About Veradigm Valuation
Our relative valuation model uses a comparative analysis of Veradigm. We calculate exposure to Veradigm's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Veradigm's related companies.Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois. Allscripts Hlthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 8000 people.
Veradigm Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 128.9 M | |
| Quarterly Earnings Growth Y O Y | -0.018 | |
| Forward Price Earnings | 15.1745 |
Additional Tools for Veradigm Stock Analysis
When running Veradigm's price analysis, check to measure Veradigm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veradigm is operating at the current time. Most of Veradigm's value examination focuses on studying past and present price action to predict the probability of Veradigm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veradigm's price. Additionally, you may evaluate how the addition of Veradigm to your portfolios can decrease your overall portfolio volatility.